Team:TU-Munich/HumanPractice/GMO

From 2013.igem.org

Revision as of 12:19, 29 August 2013 by FlorianA (Talk | contribs)


Risk-Benefit Analysis for different genetically modified plants

Example 1: Transgenic Crops

Example 2: Transgenic Moss for Phytoremediation

Assessment and Comparison

Figure 1: The Risk-Benefit balance symbolizes the cosideration of benefitial effects and potential risks that are an inheritent part of a specific technology.








Legal regulations on the release of GMO plants

Introduction

Legal regulations in the European Union

Legal Regulation World Wide

Actual Situation in Germany



References:

http://www.ncbi.nlm.nih.gov/pubmed/6327079 Edens et al., 1984

  1. http://www.ncbi.nlm.nih.gov/pubmed/6327079 Edens et al., 1984 Edens, L., Bom, I., Ledeboer, A. M., Maat, J., Toonen, M. Y., Visser, C., and Verrips, C. T. (1984). Synthesis and processing of the plant protein thaumatin in yeast. Cell, 37(2):629–33.


Retrieved from "http://2013.igem.org/Team:TU-Munich/HumanPractice/GMO"